The Cannabinoid Biosynthesis Market to Sail Through Digitized Innovation

According to the latest research by Persistence Market Research, the Cannabinoid Biosynthesis Market is set to witness growth at 15.5% rate during 2021-2031. Demand for cannabinoid biosynthesis market is expected to see positive maturation due to recreational and medical use of this addictive medicine is gaining increased legalization across the globe.

With this various medical applications are gaining ground. The environmental impact of the natural extraction of cannabinoids from cannabis plants is what will cause this market to grow in the future.

Get Sample Copy of this Report@

Cannabinoids are a natural compound found in cannabis plants also known as Cannabis sativa. In the recent times, these compounds can be synthesized in laboratories by using enzymatic reactions of materials from a manmade or plant extracted source.

Leading driver for this market is its use in treating various medical conditions like autoimmune disorders, respiratory ailments, pain management, etc. Cannabinoids in their natural form i.e. cannabis plants, exist in very minimal quantity and are very costly to produce.

Production of 2gm of cannabinoids takes about 10 kg of cannabis plants. And biosynthetic cannabinoids are cost effective in comparison with natural process. Therefore, the large environmental impact of cannabinoid production can act as a driving factor in production of biosynthesized cannabinoids.

However, when looking at the other side of the coin, artificially synthesized cannabinoids have their own set of side effects. It is said to have side effects like paranoia, heart palpitations, extreme anxiety, seizure, etc. which is not the case with its natural counterpart when used for strictly medicinal purposes. This fact can prove to be a pretty big roadblock in its market.

A 2019 article in Natures Review Neurology, ventured into creating cannabinoids like cannabidiolic acid, tetrahydrocannabivarinic, etc. from a simple source known as sugar galactose. Cannabis genes were used in producing cannabinoid analogues with the help of biosynthetic process.

Modifications in the cannabinoid analogues were noticed after variety of fatty acids were fed to the engineered yeast strains used for study. These modifications were noticed in the molecule that alters the affinity and potency of the binding process of the receptor.

This process promotes a more rigorous study of the resulting compounds and will further assist in developing treatment and management plans for variety of human ailments.

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

For the entire list of market players, request for Table of Content here@

Cannabinoids have been deemed illegal due to its severe side effects like persistent craving which can result into an addiction if not monitored properly.

According to the Federal Law, cannabis still remains illegal for sale and use. However, in the recent times, cannabis has been legalized for medicinal and recreational purposes under controlled rules and regulations by 36 states in the United States. This important fact that cannabis is attaining legal status will boost the American market at the forefront in production of biosynthetic cannabinoids.

Europe has a partial acceptance of cannabinoids. Countries like UK, Germany, Cyprus have made it a prescription medicine where in use is only allowed if the doctor prescribes it to the patient. This attains patient safety and helps in identifying measures to be taken against those dealing in cannabis illegally.

Whereas, Sweden, Latvia, Belgium, etc. have totally banned medical cannabis and one cannot import/buy/sell cannabinoids in any way. Some countries only supply it under certain set guidelines and circumstances making Europe second most important market for cannabinoid biosynthesis.

Key manufacturers in Cannabinoid Biosynthesis Market include:

  • Demetrix
  • Ginko Bioworks
  • Hyasynth Biologicals
  • Creo
  • Amyris Inc
  • Zymergen Inc
  • Cronos Group Inc
  • Constellation Brands Inc
  • Jazz Pharmaceuticals PLC
  • Canopy Growth Corp
  • Evolva Holding SA
  • Willow Biosciences Inc
  • InMed Pharmaceuticals
  • CB Therapeutics
  • Lygos
  • Purisys
  • Renew Biopharma

Pre-Book Right Now for Exclusive Analyst Support@

Key Segments

By Drug type:

  • Cannabidiol (CBD)
  • Tetrahydrocannabinol (THC)
  • Cannabigerol (CBG)
  • Tetrahydrocannabivarin (THCV)
  • Others

By Application:

  • Pain management
  • Anxiety management
  • Appetite stimulation
  • Nausea and vomit management
  • Other

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales –
Website –

Comments are closed